MDSH SRL
The score of MDSH shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -11 % Total assets -60 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →MDSH's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 May 2026
- Year ended 31 Dec 2024filed on 02 Apr 2025
- Year ended 31 Dec 2023filed on 25 Mar 2024
- Year ended 31 Dec 2022filed on 08 May 2023
- Year ended 31 Dec 2021filed on 25 May 2022
MDSH's financial analysis
- Solvency89.3%sector median: 45.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MDSH
MDSH's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0823.924.136
- VAT number
- BE0823924136
- Peppol
- Registered · 0208:0823924136 · as of 27 Oct 2026
- Legal form
- SRL
- Incorporated
- 15 Mar 2010
- Registered office
- 1050 Ixelles
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
MDSH (SRL) has been based in Ixelles since 2010, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 3,314 € and equity of 82,373 €; its revenue is not published. Its solvency stands at 89.3%, above the median of its sector (45.7%).
Companies similar to MDSH
Companies in the same business, of comparable size and area, outside its group.
- Biokey Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 2,606 €
- " Akontio " Research and experimental development on natural sciences and engineering Huy · balance sheet 69,650 €
- Europharmedtech Research and experimental development on natural sciences and engineering Ganshoren · balance sheet 54,960 €
- Herlinco Accounting, bookkeeping and auditing activities; tax consultancy Overijse · balance sheet 109,375 €
- Bogastra Business and other management consultancy activities Ghent · balance sheet 111,597 €
- Clino Consult Research and experimental development on natural sciences and engineering Beveren-Kruibeke-Zwijndrecht · balance sheet 191,749 €
- Elandd Research and experimental development on natural sciences and engineering Bonheiden · balance sheet 129,408 €
- JUNIPR Research Business and other management consultancy activities Halle · balance sheet 100,131 €
Frequently asked questions about MDSH
What is the revenue of MDSH?
MDSH files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MDSH?
In Belgium, the VAT number is the company number prefixed with BE: BE0823924136 for MDSH, if the company is VAT-registered. Its company number (CBE) is 0823.924.136.
Where is the registered office of MDSH?
According to the CBE register, the registered office of MDSH is in 1050 Ixelles.
What is the equity of MDSH?
At the close of the 2025 financial year, the equity of MDSH amounts to 82,373 €, a solvency of 89.3% of total assets.
Who manages MDSH?
The register lists 1 active mandates at MDSH. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MDSH
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →